Current assets increased 8.5%
Current assets changed +8.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$2.8B→$3.0B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ILMN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow margin moved 1023 bp higher
Free-cash-flow margin changed +1023 basis points from the comparable as-filed period.
23.34%→33.57%2 prior comparisons
Operating cash-flow margin moved 1091 bp higher
Operating cash-flow margin changed +1091 basis points from the comparable as-filed period.
26.20%→37.11%2 prior comparisons
Revenue increased 4.2%
Revenue changed +4.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.1B→$1.1B2 prior comparisons
Capital expenditure increased 29.0%
Capital expenditure changed +29.0% from the comparable as-filed period.
$31.0M→$40.0M2 prior comparisons
Total assets increased 10.3%
Total assets changed +10.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$6.2B→$6.8B4 prior comparisons
Receivables / revenue moved 188 bp lower
Receivables / revenue changed -188 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
67.25%→65.37%2 prior comparisons
Gross profit increased 13.2%
Gross profit changed +13.2% from the comparable as-filed period.
$733.0M→$830.0M2 prior comparisons
Research & development increased 6.6%
Research & development changed +6.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$229.0M→$244.0M2 prior comparisons
Cost of revenue decreased 14.8%
Cost of revenue changed -14.8% from the comparable as-filed period.
$351.0M→$299.0M2 prior comparisons
Capex / revenue moved 68 bp higher
Capex / revenue changed +68 basis points from the comparable as-filed period.
2.86%→3.54%2 prior comparisons
Shares outstanding decreased 1.0%
Shares outstanding changed -1.0% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
152,800,000→151,200,0008 prior comparisons
Stock-based compensation increased 7.1%
Stock-based compensation changed +7.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$70.0M→$75.0M2 prior comparisons
R&D / revenue moved 49 bp higher
R&D / revenue changed +49 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
21.13%→21.61%2 prior comparisons
SBC / revenue moved 19 bp higher
SBC / revenue changed +19 basis points from the comparable as-filed period.
6.46%→6.64%2 prior comparisons
Selling, general & administrative increased 1.4%
Selling, general & administrative changed +1.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$277.0M→$281.0M2 prior comparisons
Trade receivables increased 1.2%
Trade receivables changed +1.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$729.0M→$738.0M4 prior comparisons
Operating income increased 14.5%
Operating income changed +14.5% from the comparable as-filed period.
$214.0M→$245.0M2 prior comparisons
Operating margin moved 93 bp higher
Operating margin changed +93 basis points from the comparable as-filed period.
20.21%→21.14%2 prior comparisons
Revenue increased 9.4%
Revenue changed +9.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.1B→$1.2B2 prior comparisons
Current liabilities increased 8.0%
Current liabilities changed +8.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$1.5B→$1.6B4 prior comparisons
Operating cash-flow margin moved 475 bp lower
Operating cash-flow margin changed -475 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
22.10%→17.34%2 prior comparisons
Free-cash-flow margin moved 537 bp lower
Free-cash-flow margin changed -537 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
19.26%→13.89%2 prior comparisons
Current assets increased 7.3%
Current assets changed +7.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$2.6B→$2.8B4 prior comparisons
Trade receivables increased 9.0%
Trade receivables changed +9.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$701.0M→$764.0M4 prior comparisons
Capital expenditure increased 33.3%
Capital expenditure changed +33.3% from the comparable as-filed period.
$30.0M→$40.0M3 prior comparisons
Gross margin moved 81 bp higher
Gross margin changed +81 basis points from the comparable as-filed period.
65.63%→66.44%2 prior comparisons
Inventory increased 9.4%
Inventory changed +9.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$575.0M→$629.0M4 prior comparisons
Selling, general & administrative increased 16.7%
Selling, general & administrative changed +16.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$234.0M→$273.0M2 prior comparisons
Total assets increased 9.2%
Total assets changed +9.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$6.1B→$6.7B4 prior comparisons
Gross profit increased 10.8%
Gross profit changed +10.8% from the comparable as-filed period.
$695.0M→$770.0M2 prior comparisons
R&D / revenue moved 158 bp lower
R&D / revenue changed -158 basis points from the comparable as-filed period.
23.32%→21.74%2 prior comparisons
Capex / revenue moved 62 bp higher
Capex / revenue changed +62 basis points from the comparable as-filed period.
2.83%→3.45%2 prior comparisons
Cost of revenue increased 6.9%
Cost of revenue changed +6.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$364.0M→$389.0M2 prior comparisons
Shares outstanding decreased 1.8%
Shares outstanding changed -1.8% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
153,700,000→151,000,0008 prior comparisons
Research & development increased 2.0%
Research & development changed +2.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$247.0M→$252.0M2 prior comparisons
Working capital increased 6.4%
Working capital changed +6.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$1.2B→$1.3B4 prior comparisons
SBC / revenue moved 30 bp lower
SBC / revenue changed -30 basis points from the comparable as-filed period.
6.52%→6.21%2 prior comparisons
Stock-based compensation increased 4.3%
Stock-based compensation changed +4.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$69.0M→$72.0M2 prior comparisons
Receivables / revenue moved 28 bp lower
Receivables / revenue changed -28 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
66.19%→65.92%2 prior comparisons
Inventory / revenue moved 3 bp lower
Inventory / revenue changed -3 basis points from the comparable as-filed period.
54.30%→54.27%2 prior comparisons
Working capital / assets moved 50 bp lower
Working capital / assets changed -50 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
19.39%→18.89%4 prior comparisons
Current ratio decreased 0.6%
Current ratio changed -0.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
1.81→1.84 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.